2009 News

11.10.2009 Press Release

Santen Announces Financial Result for the Second Quarter ended September 30, 2009

11.10.2009 Press Release

Revision of Financial Forecast

08.04.2009 Press Release

Santen Announces Financial Result for the First Quarter ended June 30, 2009

07.03.2009 Press Release

Notice on the Exercise Price of Stock Options (Stock Acquisition Rights)

06.24.2009 Press Release

Notice on the Allotment of Stock Options (Stock Acquisition Rights)

05.12.2009 Press Release

Santen to Issue Stock Acquisition Rights to the Directors for the Purpose of Granting Stock Options

05.12.2009 Press Release

Notice on Board of Directors

05.12.2009 Press Release

Santen to Issue Stock Acquisition Rights to the Corporate Officers for the Purpose of Granting Stock Options

05.12.2009 Press Release

Santen Announces Financial Results for the Year ended March 31, 2009

04.15.2009 Press Release

Santen and Merck & Co., Inc Sign Licensing Agreement for Tafluprost, Treatment for Glaucoma and Ocular Hypertension

03.03.2009 Press Release

Santen to Launch Sante FX V Plus OTC Eye Drop

03.03.2009 Press Release

Santen Pharmaceutical Co., Ltd. (Santen) licenses development, manufacturing and marketing rights of its hydrophobic acrylic lens material to Bausch & Lomb Inc.(B&L)

02.05.2009 Press Release

Santen Announces Financial Result for the Third Quarter ended December 31, 2008